Review: taking Geodon and Adderall 10 together


Summary

Drug interactions are reported among people who take Geodon and Adderall 10 together. This review analyzes the effectiveness and drug interactions between Geodon and Adderall 10. It is created by eHealthMe based on reports of 371 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Geodon

Geodon has active ingredients of ziprasidone hydrochloride. It is often used in bipolar disorder. (latest outcomes from Geodon 17,186 users)

Adderall 10

Adderall 10 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 10 4,968 users)

On Sep, 24, 2016

371 people who take Geodon, Adderall 10 are studied.


Number of reports submitted per year:

Geodon and Adderall 10 drug interactions.

Drug effectiveness over time:

Geodon:
  • < 1 month: 44.0% - (4 of 9 people)
  • 1 - 6 months: 33.0% - (2 of 6 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 28.0% - (2 of 7 people)
  • 2 - 5 years: 66.0% - (6 of 9 people)
  • 5 - 10 years: 62.0% - (5 of 8 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Adderall 10:
  • < 1 month: 100.0% - (2 of 2 people)
  • 1 - 6 months: 45.0% - (5 of 11 people)
  • 6 - 12 months: 42.0% - (3 of 7 people)
  • 1 - 2 years: 60.0% - (3 of 5 people)
  • 2 - 5 years: 63.0% - (7 of 11 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Geodon:
  • female: 47.0% - (18 of 38 people)
  • male: 50.0% - (3 of 6 people)
Adderall 10:
  • female: 57.0% - (23 of 40 people)
  • male: 80.0% - (4 of 5 people)

Drug effectiveness by age:

Geodon:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 60.0% - (3 of 5 people)
  • 20-29: 57.0% - (4 of 7 people)
  • 30-39: 47.0% - (8 of 17 people)
  • 40-49: 36.0% - (4 of 11 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 100.0% - (1 of 1 people)
Adderall 10:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 40.0% - (2 of 5 people)
  • 20-29: 83.0% - (5 of 6 people)
  • 30-39: 47.0% - (9 of 19 people)
  • 40-49: 70.0% - (7 of 10 people)
  • 50-59: 75.0% - (3 of 4 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • malaise
  • somnolence
  • weight increased
  • abnormal behaviour
  • aggression
  • convulsion
  • decreased appetite
  • delusion of grandeur
  • depressed mood
  • drooling
1 - 6 months:
  • dizziness
  • agitation
  • anxiety aggravated
  • loss of libido
  • crying
  • hot flashes
  • hyperhidrosis
  • abnormal behaviour
  • angina pectoris
  • antisocial behaviour
6 - 12 months:
  • serotonin syndrome
  • insomnia
  • agitation
  • antisocial behaviour
  • anxiety aggravated
  • constipation
  • crying
  • decreased interest
  • dizziness aggravated
  • drug withdrawal headache
1 - 2 years:
  • constipation
  • hair loss
  • agitation
  • antisocial behaviour
  • anxiety aggravated
  • atrial fibrillation
  • bloating
  • crying
  • decreased interest
  • dizziness aggravated
2 - 5 years:
  • diabetes mellitus
  • temperature regulation disorder
  • type 2 diabetes mellitus
  • pain
  • anger
  • anxiety aggravated
  • attention deficit/hyperactivity disorder
  • bipolar disorder
  • chronic fatigue syndrome
  • coordination impairment
5 - 10 years:
  • chest pain
  • chills
  • death sudden
  • dry eye
  • heat stroke
  • hyperhidrosis
  • hypertension
  • malaise
  • musculoskeletal pain
  • atrial fibrillation
10+ years:
  • heart rate abnormal
  • mental status changes
  • muscle haemorrhage
  • muscle pain
  • temperature - normal
  • heat stroke
  • pain in jaw
  • tachycardia aggravated
  • troponin increased
not specified:
  • weight increased
  • feeling abnormal
  • drug ineffective
  • malaise
  • depression
  • fatigue
  • insomnia
  • suicidal ideation
  • type 2 diabetes mellitus
  • abnormal behaviour

Most common drug interactions by gender *:

female:
  • feeling abnormal
  • drug ineffective
  • weight increased
  • malaise
  • fatigue
  • depression
  • suicidal ideation
  • insomnia
  • pain
  • type 2 diabetes mellitus
male:
  • weight increased
  • insomnia
  • tardive dyskinesia
  • abnormal behaviour
  • diabetes mellitus
  • aggression
  • type 2 diabetes mellitus
  • convulsion
  • somnolence
  • depression

Most common drug interactions by age *:

0-1:
  • glucose tolerance impaired
2-9:
  • aggression
  • abnormal behaviour
  • weight increased
  • somnolence
  • convulsion
  • decreased appetite
  • delusion of grandeur
  • depressed mood
  • drooling
  • insomnia
10-19:
  • weight increased
  • diabetic ketoacidosis
  • type 1 diabetes mellitus
  • dyspnoea
  • diabetes mellitus
  • abnormal behaviour
  • chest discomfort
  • essential hypertension
  • hallucination, visual
  • impulse-control disorder
20-29:
  • depression
  • pain
  • blood glucose increased
  • weight increased
  • injury
  • type 2 diabetes mellitus
  • pulmonary embolism
  • anxiety
  • blood pressure increased
  • dyspnoea
30-39:
  • weight increased
  • insomnia
  • serotonin syndrome
  • diabetes mellitus
  • type 2 diabetes mellitus
  • agitation
  • drug withdrawal syndrome
  • vision blurred
  • bipolar disorder
  • depression
40-49:
  • feeling abnormal
  • depression
  • fatigue
  • suicidal ideation
  • insomnia
  • paranoia
  • tremor
  • headache
  • thinking abnormal
  • weight increased
50-59:
  • malaise
  • drug ineffective
  • feeling abnormal
  • fatigue
  • schizoaffective disorder
  • weight increased
  • somnolence
  • dyspnoea
  • ill-defined disorder
  • cough
60+:
  • tardive dyskinesia
  • atrial fibrillation
  • blood cholesterol increased
  • blood creatinine increased
  • blood triglycerides increased
  • glycosylated haemoglobin increased
  • microalbuminuria
  • type 2 diabetes mellitus
  • weight increased
  • anxiety

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Geodon and Adderall 10?

Can you answer these questions?

More questions for: Geodon, Adderall 10

You may be interested in these reviews

More reviews for: Geodon, Adderall 10

On eHealthMe, Geodon (ziprasidone hydrochloride) is often used to treat bipolar disorder. Adderall 10 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.